Si-bone Inc (NASDAQ:SIBN) Sellers Strengthened By 60.99% Their Shorts

It was reported an increase on Si-bone Inc (NASDAQ:SIBN)’s short interest with 60.99%. It was announced in February by FINRA the 295,100 short interest on SIBN. That’s 60.99% up from 183,300 shares. Former SIBN’s position will need 3 days to recover. It has 102,500 average volume.

The stock increased 7.45% or $1.42 during the last trading session, reaching $20.48.Currently SI-BONE, Inc. is after 0.00% change in last February 23, 2018. SIBN has 103,464 shares volume. SIBN the S&P 500 by 0.00%.

SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally.The company has $493.07 million market cap. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain.Last it reported negative earnings.

For more SI-BONE, Inc. (NASDAQ:SIBN) news posted briefly go to: Prnewswire.com, Benzinga.com, Seekingalpha.com, Benzinga.com or . The titles are as follows: “SI-BONE Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares – PR Newswire” posted on October 19, 2018, “Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, IPOs (Oct. 14-20) – Benzinga” on October 14, 2018, “JPMorgan downgrades Infinity Pharma to Underweight in premarket analyst action – Seeking Alpha” with a publish date: November 12, 2018, “Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results, IPOs (Nov. 11-17) – Benzinga” and the last “PayPal Stock Jumps Again: Time to Buy PYPL? – Yahoo Finance” with publication date: September 11, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.